Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apopto...
Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
About this item
Full title
Author / Creator
Ono, Masaya , Sunagawa, Yoichi , Mochizuki, Saho , Katagiri, Takahiro , Takai, Hidemichi , Iwashimizu, Sonoka , Inai, Kyoko , Funamoto, Masafumi , Shimizu, Kana , Shimizu, Satoshi , Katanasaka, Yasufumi , Komiyama, Maki , Hawke, Philip , Hara, Hideo , Arakawa, Yoshiki , Mori, Kiyoshi , Asai, Akira , Hasegawa, Koji and Morimoto, Tatsuya
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
It is well known that the anthracycline anticancer drug doxorubicin (DOX) induces cardiotoxicity. Recently, Chrysanthemum morifolium extract (CME), an extract of the purple chrysanthemum flower, has been reported to possess various physiological activities such as antioxidant and anti-inflammatory effects. However, its effect on DOX-induced cardiot...
Alternative Titles
Full title
Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8833354
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8833354
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14030683
